// App-Quantinova.ai

1257 : A MYC-Aurka protein complex represents an actionable target in p53 altered liver cancer

Researchers

Presenter

  • Dauch Daniel

Principal Investigators

  • Ramona Rudalska

  • Giacomo Cossa

  • Jean Charles Nault

  • Sandrine Imbeaud

  • Nisar P. Malek

  • Thomas Longerich

  • Stefan Laufer

  • Antti Poso

  • Jessica Zucman-Rossi

  • Martin Eilers

  • Lars Zender

Medical Centers

  • University of Tubingen, Tubingen, Germany

  • University of Wurzburg, Wurzburg, Germany

  • INSERM, Paris, France

  • Inserm, Paris, France

  • University Hospital RWTH Aachen, Aachen, Germany

  • University of Tubingen, Tubingen, Germany

Locations

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • p53

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A